HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $502,135 | -76.0% | 15,323 | -74.2% | 0.00% | -100.0% |
| Q2 2023 | $2,093,699 | +220.7% | 59,497 | +197.6% | 0.00% | – |
| Q1 2023 | $652,804 | +35.1% | 19,994 | +128.1% | 0.00% | – |
| Q4 2022 | $483,061 | +2919.1% | 8,767 | +2295.4% | 0.00% | – |
| Q3 2022 | $16,000 | -75.8% | 366 | -73.1% | 0.00% | – |
| Q2 2022 | $66,000 | -87.5% | 1,361 | -87.4% | 0.00% | – |
| Q1 2022 | $527,000 | -46.6% | 10,831 | -53.1% | 0.00% | – |
| Q4 2021 | $986,000 | +41.9% | 23,106 | +27.4% | 0.00% | – |
| Q3 2021 | $695,000 | -11.0% | 18,138 | -34.4% | 0.00% | – |
| Q2 2021 | $781,000 | +230.9% | 27,638 | +287.0% | 0.00% | – |
| Q1 2021 | $236,000 | -49.5% | 7,142 | -44.7% | 0.00% | – |
| Q4 2020 | $467,000 | -37.4% | 12,911 | -41.3% | 0.00% | – |
| Q3 2020 | $746,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |